
Counterfeiting continues to be a huge challenge affecting both branded and generic products, which, although a worldwide issue, is especially prominent in developing countries.
Stephen Kemp is business development director at Brecon Pharmaceuticals.

Published: November 1st 2011 | Updated:

Published: May 2nd 2011 | Updated: